Intended for healthcare professionals


British public will rule on fertility advances

BMJ 1994; 308 doi: (Published 15 January 1994) Cite this as: BMJ 1994;308:153
  1. L Dillner
  1. HFEA, Paxton House, 30 Artillery Lane, London E1 7LS.

    Members of the Human Fertilisation and Embryology Authority (HFEA), which licenses fertility clinics in Britain, admitted last week to feelings of unease and distaste at the idea of eggs from aborted fetuses being used to treat infertile women. They said that the public would have the largest say in whether such treatments went ahead.

    Professor Sir Colin Campbell, chairman of the authority, said that such scientific advances were everyone's concern and that the authority was trying to establish guidelines for treatments that were only two or three years away. By that time eggs and ovarian tissues from both aborted fetuses and cadavers could be used to treat infertile women.

    Professor Campbell's remarks were made at the launch of the authority's 12 page consultation document that sets out the pros and cons of potential advances in infertility treatments and calls for comments over the next five months. The HFEA brought the publication of its report forward after the media reported that a 59 year old British woman had given birth …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription